Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Auriga Research, SFRI sign MoU to build AI-integrated, globally compliant healthcare ecosystem
The partnership outlines a joint framework to support clinical trials, regulatory pathways, digital health innovation, and…
Biocon Biologics gains UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars
Vevzuo is authorised for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord…
Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData
According to GlobalData’s latest report, there is set to be a smaller proportion of global drug sales which will have patent…
FROM LAB TO LIFE BRIDGING SCIENCE AND CARE
The inaugural session of FDD Conclave 2025 set a powerful tone for the twoday event that united the industry’s brightest minds in…
Panel Discussion: Future-ready formulations: Addressing the challenges of special population
The final panel discussion on Day 2 of the FDD Conclave 2025 focused on how formulation science can evolve to better serve special…
Panel Discussion: Beyond the needle: Innovations in painless drug delivery
Drug delivery is undergoing a transformation driven by the demand for patient-friendly, painfree alternatives. As pharma R&D…
Panel Discussion: Topical and transdermal drug delivery: The rise of non-invasive therapies
As the push for non-invasive, patient-centric treatment options intensifies, topical and transdermal drug delivery systems are…
Keynote Address by Dr Pavan Bhat, CEO, Inventia Healthcare
Day two at the FDD Conclave 2025 began with a highly insightful and motivating keynote address by Dr Pavan Bhat, CEO, Inventia…
FDD Leadership Awards 2025 celebrates the changemakers of FR&D
The seventh edition of the FDD Leadership Awards, and held alongside the FDD Conclave 2025, continued to uphold its legacy of…
Panel Discussion: Biologics and biosimilars: The next leap in patient-centric drug development
The panel discussion titled ‘Biologics and Biosimilars: The Next Leap in Patient-Centric Drug Development’ at the FDD Conclave…